06/11/2025
5:25 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:18 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
05/15/2025
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:00 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
11:40 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GALT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/28/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:03 PM | CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:03 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:04 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:05 PM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:07 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:02 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
10:15 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
6:45 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:20 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:16 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:02 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:07 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:17 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:18 PM | Galectin Therapeutics (Subject)
LEWIS JOEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:19 PM | Galectin Therapeutics (Subject)
Jamil Khurram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
12/03/2024
7:04 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
12/03/2024
7:05 AM | Galectin Therapeutics (Filer)
| Form ARS | |
11/14/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
12:39 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Gold is soaring. Here’s how to get paid from it (Ad) Gold just broke through $3,300…
And while the headlines shout about price targets, something even more powerful is happening behind the scenes…
Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge.
No trading gold futures. No mining stocks. No vaults.
Just a simple fund delivering monthly payouts — like clockwork. Click here to discover the income ETF behind it all. |
10/16/2024
3:12 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:10 PM | Boudes Pol F (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
7:08 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:41 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
7:38 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
8:43 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4/A | |
07/23/2024
8:38 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
12:55 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy GALT Stock Free GALT Stock Alerts